Skip to main content
PRESCRIBING MOUNJARO (TIRZEPATIDE) IN GENERAL PRACTICE FOR WEIGHT LOSS 
Although NICE issued guidance in December 2024 that the NHS should provide MOUNJARO (Tirzepatide) to patients for weight loss from June 2025 It has NOT been confirmed by Leicestershire, Leicester, and

Patient participation group

The aims of the patient participation group

  • To offer opinions in a constructive manner and to put forward ideas on behalf of other patients.
  • To improve the provision of health care.
  • To improve communication between surgery, patients and the wider community about matters concerning the surgery and health in general.
  • To provide assistance in development of new services.
  • To encourage a spirit of self help and support amongst patients to improve their health and social care.

Page last reviewed: 24 April 2025
Page created: 24 April 2025